Stability of refractive outcomes after hyperopic LASIK with and without mitomycin-C application

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029971

Enrollment

100

Registered

2022-08-29

Start date

2023-04-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H52.0

Interventions

Group 1: hyperopic LASIK with MMC use Group 2: conventional hyperopic LASIK (Laser-assisted in situ keratomileusis)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adult hyperopic LASIK patients capable of giving consent Age > 21 years Hyperopia between +1.00 and +6.00D

Exclusion criteria

Exclusion criteria: Systemic diseases with impairment of wound healing Other eye diseases Past refractive surgical procedures Postoperative over/under correction (> ±0.5 D) No 1-year follow-up possible Patient's objection to data analysis

Design outcomes

Primary

Measure	Time frame
Standard target parameters: visual acuity, spherical equivalents and refractive astigmatism	—

Secondary

Measure	Time frame
Visual acuity	—

Countries

Germany

Contacts

Public ContactAndreas Frings

Heinrich-Heine-Universität Düsseldorf

info@augenarzt-frings.de+49 911 235 558 25

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026